VPACX | VPADX | VPACX / VPADX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 35 years | 24 years | - |
Gain YTD | 5.395 | 5.459 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.74B | 9.74B | 100% |
Annual Yield % from dividends | 2.99 | 3.12 | 96% |
Returns for 1 year | 1.60 | 1.61 | 99% |
Returns for 3 years | 1.90 | 2.00 | 95% |
Returns for 5 years | 14.81 | 14.93 | 99% |
Returns for 10 years | 29.93 | 30.23 | 99% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 16.04 | 0.06 | +0.38% |
ProShares UltraShort Nasdaq Biotech | |||
GHTA | 29.76 | -0.12 | -0.39% |
Goose Hollow Tactical Allocation ETF | |||
FDEM | 26.33 | -0.11 | -0.43% |
Fidelity Emerging Markets Mltfct ETF | |||
ICF | 61.87 | -0.44 | -0.71% |
iShares Cohen & Steers REIT ETF | |||
NUMG | 45.83 | -1.23 | -2.61% |
Nuveen ESG Mid-Cap Growth ETF |